Development of patient-derived xenograft (PDX) models for pancreatic carcinoma as a preclinical platform for drug development

被引：0
|
作者：
Ricono, Jill
Thatte, Jayant
Scott, Colleen
Broudy, Thomas B.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-5185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5185
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Development of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development
    Mullins, Chelsea
    Ricono, Jill
    Nair, Praveen
    Mirsaidi, Cyrus
    Broudy, Thomas
    CANCER RESEARCH, 2015, 75
  • [2] Establishment of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development
    Carlson, Patrick
    Ricono, Jill
    Mullins, Chelsea
    Broudy, Thomas
    Mirsaidi, Cyrus
    Nair, Praveen
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Development of patient-derived xenograft (PDX) models for gastrointestinal stromal tumors (GIST) as a pre-clinical platform for drug development
    Ricono, Jill
    Mullins, Chelsea
    Nair, Praveen
    Mirsaidi, Cyrus
    Broudy, Thomas
    CANCER RESEARCH, 2015, 75
  • [4] Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer
    Behrens, Diana
    Buettner, Britta
    Lawlor, Rita L.
    Heeschen, Christopher
    Buchholz, Malte
    Siveke, Jens
    Wengner, Antje M.
    Saluja, Ashok
    Hoffmann, Jens
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer
    Behrens, D.
    Lawlor, R. T.
    Heeschen, C.
    Buchholz, M.
    Siveke, J.
    Wengner, A.
    Saluja, A.
    Buettner, B.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E101 - E101
  • [6] Development of breast cancer patient-derived xenograft models as preclinical tool for drug discovery
    Rymer, Isha C.
    Wang, Jinwei
    Zhu, Zhou
    Schwab, Richard
    Wallace, Anne M.
    Blair, Sarah L.
    Greenberg, Norman
    Yang, Wei J.
    CANCER RESEARCH, 2011, 71
  • [7] Patient-Derived Xenograft Models(PDX) of Lung Squamous Cell Carcinoma(SCC) for Preclinical Studies
    Kim, T. H.
    Lee, J.
    Park, B.
    Kim, H. K.
    Lee, J.
    Hwang, E.
    Lee, H.
    Koo, K.
    Lee, H.
    Lee, S.
    Rhee, H.
    Lee, J. E.
    Choi, Y.
    Kim, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S987 - S988
  • [8] DEVELOPMENT OF A PANEL OF PATIENT-DERIVED XENOGRAFT (PDX) MODELS FROM BRAIN METASTASES
    Sarkaria, Jann
    Ma, Daniel
    Schroeder, Mark
    Carlson, Brett
    Giannini, Caterina
    Parney, Ian
    NEURO-ONCOLOGY, 2014, 16
  • [9] XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS), an update on a preclinical platform for early drug testing
    Wozniak, Agnieszka
    Cornillie, Jasmien
    Gebreyohannes, Yemarshet K.
    Wellens, Jasmien
    Vreys, Lise
    Hompes, Daphne
    Stas, Marguerite
    Sinnaeve, Friedl
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    CANCER RESEARCH, 2017, 77
  • [10] XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS)-an update on a preclinical platform for early drug testing
    Wozniak, Agnieszka
    Cornillie, Jasmien
    Gebreyohannes, Yemarshet K.
    Wang, Yannick
    Wellens, Jasmien
    Vanleeuw, Ulla
    Hompes, Daphne
    Stas, Marguerite
    Sinnaeve, Friedl
    Wafa, Hazem
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    CANCER RESEARCH, 2018, 78 (13)
12345